Molecular detection of minimal residual disease in colorectal and breast cancer.
about
Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC).Histopathological detection of lymph node metastases from colorectal carcinoma.Occult axillary lymph node metastases are of no prognostic significance in breast cancer.Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue.Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
P2860
Molecular detection of minimal residual disease in colorectal and breast cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Molecular detection of minimal residual disease in colorectal and breast cancer.
@ast
Molecular detection of minimal residual disease in colorectal and breast cancer.
@en
type
label
Molecular detection of minimal residual disease in colorectal and breast cancer.
@ast
Molecular detection of minimal residual disease in colorectal and breast cancer.
@en
prefLabel
Molecular detection of minimal residual disease in colorectal and breast cancer.
@ast
Molecular detection of minimal residual disease in colorectal and breast cancer.
@en
P2093
P2860
P1433
P1476
Molecular detection of minimal residual disease in colorectal and breast cancer.
@en
P2093
Cleton-Jansen AM
Liefers GJ
Tollenaar RA
P2860
P304
P356
10.1046/J.1365-2559.1999.00716.X
P577
1999-05-01T00:00:00Z